Howlader N,Noone A,Krapcho M,Garshell J,Miller D,Altekruse SF .1975 .National Cancer Institute. SEER cancer statistics review, : 2012.
Lejman M,Chalupnik A,Chilimoniuk Z,Dobosz M. .2022 .Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukaemia in children. Int J Mol Sci, 10(5) : 2755.
Malard F,Mohty M. .2020 .Acute lymphoblastic leukaemia. Lancet, 6736(19) : 33018-1.
Tsagarakis NJ,Papadhimitriou SI,Pavlidis D,Marinakis T,Kostopoulos IV,Stiakaki E .2019 .Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B acute lymphoblastic leukaemia. Int J Lab Hematol, 10(3) : 364-72.
Qian M,Zhao X,Devidas M,Yang W,Gocho Y,Smith C .2019 .Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukaemia in children. J Natl Cancer Inst, 10(12) : 1350-7.
Liang P,Miao M,Wang Z,Jiang H,Ma W,S W .2018 .CD9 expression indicates a poor outcome in acute lymphoblastic leukaemia. Cancer Biomark, 10(4) : 781-6.
Blunck CB,Granado ET,Noronha EP,Wajnberg G,Passetti F,de-Oliveira MSP .2018 .CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukaemia. Hematol Transfus Cell Ther, 08(3) : 205-11.
Robert JH,Amoussou NG,Mai HL,Loge C,Brouard S C .2020 .Useful multifunction proteins for the possible design and development of small-molecule therapeutic tools. Drug Discov Today, 10(1) : 56-68.
Richardson MM,Jennings LK,Zhang XA .2011 .Tetraspanins and tumour progression. Clin Exp Metastasis, 10(3) : 261-70.
Pacienza N,Yannarelli G. .2019 .CD9: A possible clue into breast cancer chemoresistance. Oncotarget, 10(47) : 4921-3.
Kulis J,Wawrowski L,Sedek L,Wrobel L,Slota L,van der Velden VHJ .2022 .Machine learning based analysis of relations between antigen expression and genetic aberrations in childhood B-cell precursor acute lymphoblastic leukaemia. J Clin Med, 10(9) : 2281.
Kulis J,Sedek L,Slota L,Perkowski B,Szczepanski T. .2022 .Commonly assessed markers in childhood BCP-ALL diagnostic panels and their association with genetic aberrations and outcome prediction. Genes (Basel), 10(8) : 1374.
Swerdlow SH,Campo E,Harris NL,Pileri ES,Stein SA,H SA .2008 .Classi cation_of_Tumours_of_the_Haematopoietic_. , : .
Koh HM,Jang BG,Lee DH,Hyun CL .2021 .Increased CD9 expression predicts favorable prognosis in human cancers: A systematic review and meta-analysis. Cancer Cell Int, 10(1) : 472.
Sahar M,Gul S,Shehzad F,Mohsin S. .2020 .Demographic features of pediatric B-ALL (B lineage acute lymphoblastic leukaemia) patients in Pakistani population. Prof Med J, 10(8) : 1582-9.
Touzet L,Dumezy F,Roumier C,Berthon C,Bories C,Quesnel B .2007 .CD9 in acute myeloid leukaemia: Prognostic role and usefulness to target leukemic stem cells. Cancer Med, 10(3) : 1279-88.
Wang W,Gao L,Li Y,Li ZL,Gong M,Huang FZ .2015 .The application of CD73 in minimal residual disease monitoring using ow cytometry in B-cell acute lymphoblastic leuka-emia. Leuk Lymphoma, 1070153(5) : 1174-81.
Gupta DG,Varma N,Naseem S,Sachdeva MUS,Bose P,Binota J .2021 .Characterisation of immunophenotypic aberrancies with respect to common fusion transcripts in B-cell precursor acute lymphoblastic leukaemia: A report of 986 Indian patients. Turk J Haematol, 0326(1) : 1-2.
Leung KT,Zhang C,Chan KYY,Li K,Cheung JTK,Ng MHL .2020 .CD9 blockade suppresses disease progression of high- risk pediatric B-cell precursor acute lymphoblastic leukaemia and enhances chemosensitivity. Leukemia, 10(3) : 709-20.
Abdulateef NAB,Ismail MM,Aljedani H. .2014 .Clinical signi - cance of co-expression of aberrant antigens in acute leukaemia: A retrospective cohort study in Makah Al Mukaramah, Saudi Arabia. Asian Pac J Cancer Prev, 15(1) : 221-7.
Esh SS,Azizi NMA,Elsafy U,Sherief LM,Zakaria M,Abdalah MM .2017 .Can CD34/CD123 distinguish between normal and leukemic B-cell precursors?. Egypt J Haematol, 10(4) : 17-60.
Leung KT,Cai J,Liu Y,Chan KYY,Shao J,Yang H .2024 .Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: Insights from a nationwide multicenter study in China. Leukemia, 10(1) : 1-8.